ClinicalTrials.gg
Enrolling by invitationNCT06980714Updated May 20, 2025

Powered vs. Manual Toothbrushing in Stage 3-4 Periodontitis

An interventional study of Powered and Manual in Periodontitis, Dental Plaque and Gingival Bleeding, sponsored by University of L'Aquila. Enrolling by invitation at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-20.

Sponsored by University of L'Aquila · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2024, registered May 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 85 studies in Periodontitis with a site in Italy — 24 open to participants now, 26 under way, none of them phase 3. Periodontitis · Italy.

Planned enrollment
28th of 61
50 · median 46
Started
2024
with 13 others
No phase
57 of 85
15 open now
Primary completion
2026-12
later than 20 of 25 live
Registered
64th of 85
by date
Lead sponsor
6 of 85
University of L'Aquila

Among the 85 studies in Periodontitis with a site in Italy, this one is the 28th largest by planned enrollment of the 61 interventional ones that give a count, is one of 14 that started in 2024, is one of 57 with no phase, reaches primary completion later than 20 of the 25 other live ones, and was the 64th registered.

Periodontitis

1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.

Browse Periodontitis studies →

Open to participants now

24 of the 85 studies in Periodontitis with a site in Italy are open now. Recruiting first, the newest first:

19 more — sign in →

All 24 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 163 Periodontitis studies recruiting now, 80 (49%) set no upper age limit and 62 (38%) stop at 75 or younger; 12 take children under 18; 80 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Periodontitis with a site in Italy, or all of them as a file.
02

Study summary

This study compares the effectiveness of powered and manual toothbrushes in reducing gum bleeding and dental plaque in people with stage 3 or 4 periodontitis. All participants are trained to brush for at least two minutes twice a day. The goal is to find out whether using a powered toothbrush leads to better oral hygiene results than a manual one, when brushing time is standardized. The study will measure bleeding and plaque levels at the beginning and over a 6-month period.

Read the detailed description

This single-blind, randomized controlled trial evaluates the clinical effectiveness of powered versus manual toothbrushing in patients newly diagnosed with stage 3 or 4 periodontitis. Participants are randomly assigned to one of two groups: powered toothbrush (Oral-B iO6) or manual toothbrush (TePe Select Soft). All participants receive standardized oral hygiene instructions and are instructed to brush twice daily for a minimum of two minutes. Manual brush users are required to use a smartphone app to monitor and record brushing duration. The use of adjunctive oral hygiene aids, such as mouthwash or interdental cleaners, is restricted throughout the study period. The primary clinical outcomes are full-mouth bleeding score (FMBS) and full-mouth plaque score (FMPS), measured at baseline and at follow-ups of 7 days, 1 month, 3 months, and 6 months.

03

Conditions studied

  • Periodontitis
  • Dental Plaque
  • Gingival Bleeding

Keywords

  • Periodontitis
  • Full-Mouth Plaque Score
  • Full-Mouth Bleeding Score
  • Home Oral Hygiene
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 75 years
  • Diagnosis of stage 3 or 4 periodontitis based on clinical and radiographic examination
  • Retaining at least 16 natural teeth
  • Ability to follow oral hygiene instructions and compliance with the study protocol
  • Willingness to refrain from using additional oral hygiene products (e.g., mouthwash, interdental cleaners) during the study
  • Ability to provide

Exclusion criteria

Exclusion Criteria:

  • Presence of systemic conditions that may affect oral health (e.g., uncontrolled diabetes, states)
  • Pregnancy or breastfeeding
  • Ongoing use of antibiotics or other medications that could interfere with gum health
  • Severe dental conditions (e.g., tooth mobility > 2, advanced root resorption)
  • Prior use of a powered toothbrush within the last 6 months
  • Participation in another clinical trial that could interfere with study outcomes
  • Inability or unwillingness to comply with study requirements or provide
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Manual

    Participants assigned to this arm use a manual toothbrush (TePe Select Soft) to perform twice-daily toothbrushing for at least 2 minutes. Brushing technique and duration are standardized through individual instruction at baseline. Participants are instructed not to use any additional oral hygiene aids, including mouthwash or interdental cleaners. Brushing sessions are monitored and recorded via a smartphone app to ensure compliance with the 2-minute minimum duration.

    Behavioral: Manual

  • Experimental
    Powered

    Participants assigned to this arm use a powered toothbrush (Oral-B iO6) to perform twice-daily toothbrushing for at least two minutes. Brushing technique and duration are standardized through individual instruction at baseline. Participants are instructed not to use any additional oral hygiene aids, including mouthwash or interdental cleaners. The powered toothbrush provides consistent brushing performance, and participants are monitored to ensure compliance with the 2-minute minimum duration.

    Behavioral: Powered

Interventions

  • BehavioralPowered

    The intervention involves the use of the Oral-B iO6 powered toothbrush, which provides oscillating-rotating brushing action with personalized feedback via its smart pressure sensor and app integration. Participants in this group are instructed to brush for at least two minutes twice daily. The toothbrush is designed to ensure consistent brushing performance, with real-time feedback on brushing technique and duration, allowing for improved oral hygiene habits. The intervention aims to standardize brushing duration and technique, eliminating potential variations found with manual brushing.

  • BehavioralManual

    The intervention involves the use of the TePe Select Soft manual toothbrush, which features soft bristles for gentle yet effective plaque removal. Participants in this group are instructed to brush for at least two minutes twice daily, with guidance on proper brushing technique. To ensure compliance with the brushing duration, participants are required to use a smartphone app that tracks and records their brushing sessions. The manual toothbrush allows for participant control over brushing pressure and technique, with no additional oral hygiene aids allowed during the study period.

06

What researchers measure

Primary outcomes

  1. Full-Mouth Bleeding Score (FMBS)

    The Full-Mouth Bleeding Score (FMBS) will be used to assess the level of gingival bleeding upon gentle probing across all teeth in the mouth. This measure will evaluate the overall gum health of participants and will help compare the effectiveness of the powered versus manual toothbrushes in reducing gingival inflammation. FMBS will be recorded at baseline, 7 days, 1 month, 3 months, and 6 months to monitor changes in bleeding over time.

    Time frame: FMBS will be assessed at baseline and at 7 days, 1 month, 3 months, and 6 months following the intervention.

Secondary outcomes

  1. Systolic and Diastolic Blood Pressure (SBP and DBP)

    Systolic and Diastolic Blood Pressure (SBP and DBP) will be measured using the Omron M6 device, following the European Society of Hypertension (ESH) guidelines for proper measurement techniques. Blood pressure will be recorded to evaluate any potential changes related to the oral hygiene interventions. Measurements will be taken at baseline, 1 month, 3 months, and 6 months to monitor any trends in blood pressure variation over the course of the study.

    Time frame: SBP and DBP will be measured at baseline, 1 month, 3 months, and 6 months.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Yes, individual participant data (IPD) will be shared with qualified researchers upon request, following ethical guidelines and the necessary approvals. The data will be anonymized and shared through a secure data repository to ensure privacy and confidentiality.

Time frame: Starting 12 months after publication; available for 3 years

Access criteria: Researchers with a methodologically sound proposal and ethics approval

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 25 months after the start.

Of 484 non-industry interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's planned 25 months is above that.

Counting every sponsor, half of 498 studies reached it within 15 months; a quarter within 8 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2025
First posted
May 20, 2025
StartActual
Nov 1, 2024
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
May 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06980714
Lead sponsor
University of L'Aquila
Responsible party
Davide Pietropaoli (PI Davide Pietropaoli, Professor, University of L'Aquila) — Principal investigator
First posted
May 20, 2025
Start date
Nov 1, 2024
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 20, 2025

Study contacts

Davide Pietropaoli, DDS, PhD
principal investigator · University of L'Aquila

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion